Cargando…
OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma
BACKGROUND: OCT4 and BIRC5 are preferentially expressed in human cancer cells and mediate cancer cell survival and tumor maintenance. However, the molecular mechanism that regulates OCT4 and BIRC5 expression is not well characterized. METHODS: By manipulating OCT4 and BIRC5 expression in hepatocellu...
Autores principales: | Cao, Lu, Li, Chunguang, Shen, Shuwen, Yan, Yan, Ji, Weidan, Wang, Jinghan, Qian, Haihua, Jiang, Xiaoqing, Li, Zhigang, Wu, Mengchao, Zhang, Ying, Su, Changqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583731/ https://www.ncbi.nlm.nih.gov/pubmed/23433354 http://dx.doi.org/10.1186/1471-2407-13-82 |
Ejemplares similares
-
OCT4 Positively Regulates Survivin Expression to Promote Cancer Cell Proliferation and Leads to Poor Prognosis in Esophageal Squamous Cell Carcinoma
por: Li, Chunguang, et al.
Publicado: (2012) -
Sulfatase 1 (hSulf-1) reverses basic fibroblast growth factor-stimulated signaling and inhibits growth of hepatocellular carcinoma in animal model
por: Xu, Gaoya, et al.
Publicado: (2014) -
Transcriptional factor OCT4 promotes esophageal cancer metastasis by inducing epithelial-mesenchymal transition through VEGF-C/VEGFR-3 signaling pathway
por: Li, Chunguang, et al.
Publicado: (2017) -
BIRC7 is Beneficial for Melanoma Progression and Hypoxic Response
por: Xu, Haiting, et al.
Publicado: (2022) -
MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2
por: Li, Yan-Li, et al.
Publicado: (2016)